Citizens Business Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Citizens Business Bank’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,500	Closed	-$510K	–	123
2022 Q2	$510K	Hold	3,500	–	–	0.07%	191
2022 Q1	$572K	Hold	3,500	–	–	0.07%	190
2021 Q4	$594K	Hold	3,500	–	–	0.07%	195
2021 Q3	$661K	Hold	3,500	–	–	0.09%	183
2021 Q2	$593K	Hold	3,500	–	–	0.08%	193
2021 Q1	$494K	Hold	3,500	–	–	0.07%	191
2020 Q4	$455K	Hold	3,500	–	–	0.07%	195
2020 Q3	$510K	Hold	3,500	–	–	0.09%	172
2020 Q2	$518K	Hold	3,500	–	–	0.09%	176
2020 Q1	$381K	Hold	3,500	–	–	0.08%	187
2019 Q4	$403K	Hold	3,500	–	–	0.07%	200
2019 Q3	$281K	Hold	3,500	–	–	0.05%	222
2019 Q2	$254K	Hold	3,500	–	–	0.04%	231
2019 Q1	$327K	Hold	3,500	–	–	0.06%	219
2018 Q4	$255K	Hold	3,500	–	–	0.05%	239
2018 Q3	$306K	Hold	3,500	–	–	0.05%	241
2018 Q2	$345K	Hold	3,500	–	–	0.06%	230
2018 Q1	$417K	Hold	3,500	–	–	0.07%	217
2017 Q4	$445K	Hold	3,500	–	–	0.07%	222
2017 Q3	$411K	Hold	3,500	–	–	0.07%	224
2017 Q2	$279K	Buy	+3,500	New	+$224K	0.05%	250

Other funds holding ALNY

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Citizens Business Bank's ALNY Position: Q3 2022 in Review

Citizens Business Bank sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2022, closing a stake of 3,500 shares — an estimated $510K sold.

Citizens Business Bank first reported a position in ALNY in Q2 2017 and held it in 21 quarters. The position peaked at $661K in Q3 2021. 497 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

Citizens Business Bank reported no remaining Alnylam Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Citizens Business Bank sold 3,500 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $510K.
Citizens Business Bank first reported a position in Alnylam Pharmaceuticals in Q2 2017 and held it in 21 quarters.
Citizens Business Bank's Alnylam Pharmaceuticals position peaked at $661K in Q3 2021.
497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Citizens Business Bank's 13F filing for Q3 2022, filed 4 Nov 2022.